Mechanical vibration inhibits osteoclast formation by reducing DC-STAMP receptor expression in osteoclast precursor cells.

Abstract:

:It is well known that physical inactivity leads to loss of muscle mass, but it also causes bone loss. Mechanistically, osteoclastogenesis and bone resorption have recently been shown to be regulated by vibration. However, the underlying mechanism behind the inhibition of osteoclast formation is yet unknown. Therefore, we investigated whether mechanical vibration of osteoclast precursor cells affects osteoclast formation by the involvement of fusion-related molecules such as dendritic cell-specific transmembrane protein (DC-STAMP) and P2X7 receptor (P2X7R). RAW264.7 (a murine osteoclastic-like cell line) cells were treated with 20ng/ml receptor activator of NF-κB ligand (RANKL). For 3 consecutive days, the cells were subjected to 1h of mechanical vibration with 20μm displacement at a frequency of 4Hz and compared to the control cells that were treated under the same condition but without the vibration. After 5days of culture, osteoclast formation was determined. Gene expression of DC-STAMP and P2X7R by RAW264.7 cells was determined after 1h of mechanical vibration, while protein production of the DC-STAMP was determined after 6h of postincubation after vibration. As a result, mechanical vibration of RAW264.7 cells inhibited the formation of osteoclasts. Vibration down-regulated DC-STAMP gene expression by 1.6-fold in the presence of RANKL and by 1.4-fold in the absence of RANKL. Additionally, DC-STAMP protein production was also down-regulated by 1.4-fold in the presence of RANKL and by 1.2-fold in the absence of RANKL in RAW264.7 cells in response to mechanical vibration. However, vibration did not affect P2X7R gene expression. Mouse anti-DC-STAMP antibody inhibited osteoclast formation in the absence of vibration. Our results suggest that mechanical vibration of osteoclast precursor cells reduces DC-STAMP expression in osteoclast precursor cells leading to the inhibition of osteoclast formation.

journal_name

Bone

journal_title

Bone

authors

Kulkarni RN,Voglewede PA,Liu D

doi

10.1016/j.bone.2013.08.020

subject

Has Abstract

pub_date

2013-12-01 00:00:00

pages

493-8

issue

2

eissn

8756-3282

issn

1873-2763

pii

S8756-3282(13)00335-9

journal_volume

57

pub_type

杂志文章

相关文献

BONE文献大全
  • Effects of Src kinase inhibition by saracatinib (AZD0530) on bone turnover in advanced malignancy in a Phase I study.

    abstract::Saracatinib (AZD0530) is an orally active once-daily Src kinase inhibitor which modulates key signaling pathways in cancer cells. In a Phase I study in patients with advanced solid malignancies resistant to standard treatment we assessed the effect of saracatinib on bone turnover. Fifty-one patients were randomized in...

    journal_title:Bone

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1016/j.bone.2011.12.017

    authors: Hannon RA,Finkelman RD,Clack G,Iacona RB,Rimmer M,Gossiel F,Baselga J,Eastell R

    更新日期:2012-04-01 00:00:00

  • Time course of "escape" from calcitonin-induced inhibition of motility and resorption of disaggregated osteoclasts.

    abstract::The reversible calcitonin (CT)-induced inhibition of osteoclastic activity has been studied to clarify the mechanisms responsible for the so-called "escape phenomenon." Osteoclasts disaggregated from neonatal rabbits were cultured on glass coverslips or thin bovine bone slices. Resorption activity was evaluated by usi...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/8756-3282(89)90010-0

    authors: Kanehisa J

    更新日期:1989-01-01 00:00:00

  • A theoretical analysis of the contributions of remodeling space, mineralization, and bone balance to changes in bone mineral density during alendronate treatment.

    abstract::In patients with osteoporosis, alendronate treatment causes an increase in bone mineral density (BMD) and a decrease in fracture incidence. Alendronate acts by changing the bone remodeling process. Changes in bone remodeling resulting in decreased remodeling space, increased bone balance per remodeling cycle, and incr...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/s8756-3282(01)00613-5

    authors: Hernandez CJ,Beaupré GS,Marcus R,Carter DR

    更新日期:2001-12-01 00:00:00

  • Association of High-resolution Peripheral Quantitative Computed Tomography (HR-pQCT) bone microarchitectural parameters with previous clinical fracture in older men: The Osteoporotic Fractures in Men (MrOS) study.

    abstract::High-resolution peripheral quantitative computed tomography (HR-pQCT) assesses both volumetric bone mineral density (vBMD) and trabecular and cortical microarchitecture. However, studies of the association of HR-pQCT parameters with fracture history have been small, predominantly limited to postmenopausal women, often...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2018.05.005

    authors: Fink HA,Langsetmo L,Vo TN,Orwoll ES,Schousboe JT,Ensrud KE,Osteoporotic Fractures in Men (MrOS) Study Group.

    更新日期:2018-08-01 00:00:00

  • The increased in vitro osteoclastogenesis in patients with rheumatoid arthritis is due to increased percentage of precursors and decreased apoptosis - the In Vitro Osteoclast Differentiation in Arthritis (IODA) study.

    abstract::Increases in local and systemic bone resorption are hallmarks of rheumatoid arthritis (RA). Osteoclasts are implicated in these processes and their enhanced differentiation may contribute to bone destruction. We observed that in vitro osteoclastogenesis varies among healthy individuals and hypothesized that increased ...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2010.10.167

    authors: Durand M,Boire G,Komarova SV,Dixon SJ,Sims SM,Harrison RE,Nabavi N,Maria O,Manolson MF,Mizianty M,Kurgan L,de Brum-Fernandes AJ

    更新日期:2011-03-01 00:00:00

  • Screening for GNAS genetic and epigenetic alterations in progressive osseous heteroplasia: first Italian series.

    abstract::Progressive osseous heteroplasia (POH) is a rare autosomal dominant disorder of mesenchymal differentiation characterized by progressive heterotopic ossification (HO) of dermis, deep connective tissues and skeletal muscle. Usually, initial bone formation occurs during infancy as primary osteoma cutis (OC) then progres...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2013.06.015

    authors: Elli FM,Barbieri AM,Bordogna P,Ferrari P,Bufo R,Ferrante E,Giardino E,Beck-Peccoz P,Spada A,Mantovani G

    更新日期:2013-10-01 00:00:00

  • Low osteocalcin/collagen type I bone gene expression ratio is associated with hip fragility fractures.

    abstract:INTRODUCTION:Osteocalcin (OC) is the most abundant non-collagenous bone protein and is determinant for bone mineralization. We aimed to compare OC bone expression and serum factors related to its carboxylation in hip fragility fracture and osteoarthritis patients. We also aimed to identify which of these factors were a...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2012.08.129

    authors: Rodrigues AM,Caetano-Lopes J,Vale AC,Vidal B,Lopes A,Aleixo I,Polido-Pereira J,Sepriano A,Perpétuo IP,Monteiro J,Vaz MF,Fonseca JE,Canhão H

    更新日期:2012-12-01 00:00:00

  • Combined treatment with PTH (1-34) and OPG increases bone volume and uniformity of mineralization in aged ovariectomized rats.

    abstract::The combination of PTH with OPG has been proposed as a potential therapy in patients with severe osteoporosis. In the present study, we examined the bone material of aged ovariectomized (OVX) rats treated either with PTH (1-34) or OPG alone or in combination of both. The micro- and nanostructural characteristics of th...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2005.03.013

    authors: Valenta A,Roschger P,Fratzl-Zelman N,Kostenuik PJ,Dunstan CR,Fratzl P,Klaushofer K

    更新日期:2005-07-01 00:00:00

  • CSF-1 blockade impairs breast cancer osteoclastogenic potential in co-culture systems.

    abstract::Metastatic bone disease has a major impact on the morbidity and mortality of breast cancer patients, and studies on bone metastasis biology have led to the development of the most widely used drugs for bone metastases treatment: zoledronate (Zol) and denosumab (Den). The aim of the present study was to assess the effe...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2014.06.017

    authors: Liverani C,Mercatali L,Spadazzi C,La Manna F,De Vita A,Riva N,Calpona S,Ricci M,Bongiovanni A,Gunelli E,Zanoni M,Fabbri F,Zoli W,Amadori D,Ibrahim T

    更新日期:2014-09-01 00:00:00

  • Sclerostin levels and bone turnover markers in adolescents with anorexia nervosa and healthy adolescent girls.

    abstract::Sclerostin, product of the SOST gene, is an important determinant of bone formation and resorption. Adolescents with anorexia nervosa (AN) have low bone density and decreased levels of bone turnover markers. However, sclerostin has not been examined in AN as a potential mediator of impaired bone metabolism. Our study ...

    journal_title:Bone

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.bone.2012.06.006

    authors: Faje AT,Fazeli PK,Katzman DK,Miller KK,Breggia A,Rosen CJ,Mendes N,Klibanski A,Misra M

    更新日期:2012-09-01 00:00:00

  • The protective role of bone morphogenetic protein-8 in the glucocorticoid-induced apoptosis on bone cells.

    abstract::One of the side effects associated with glucocorticoid therapy is glucocorticoid-induced bone loss. Glucocorticoids partly detain bone formation via the inhibition of osteoblastic function, however, the exact mechanism of this inhibition remains elusive. In this study, we examined the effect of dexamethasone, an activ...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2011.01.017

    authors: Kósa JP,Kis A,Bácsi K,Balla B,Nagy Z,Takács I,Speer G,Lakatos P

    更新日期:2011-05-01 00:00:00

  • Mineralization pathways in the active murine epiphyseal growth plate.

    abstract::Endochondral ossification in the growth plate of long bones involves cartilage mineralization, bone formation and the budding vasculature. Many of these processes take place in a complex and dynamic zone, the provisional ossification zone, of the growth plate. Here we investigate aspects of mineralization in 2D and 3D...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2019.115086

    authors: Haimov H,Shimoni E,Brumfeld V,Shemesh M,Varsano N,Addadi L,Weiner S

    更新日期:2020-01-01 00:00:00

  • Effect of inducible bone morphogenetic protein 2 expression on the osteogenic differentiation of dental pulp stem cells in vitro.

    abstract::Bone morphogenetic protein 2 (BMP-2) is a member of the transforming growth factor-β superfamily, it is known to be a factor involved in skeletal development and capable of inducing in vitro osteogenic differentiation of mesenchymal stem cells (MSCs). Dental pulp stem cells (DPSCs) isolated from extracted third molar ...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2019.115214

    authors: Tóth F,Gáll JM,Tőzsér J,Hegedűs C

    更新日期:2020-03-01 00:00:00

  • Effect of modification of hydroxyapatite/collagen composites with sodium citrate, phosphoserine, phosphoserine/RGD-peptide and calcium carbonate on bone remodelling.

    abstract::This study describes the early interface reaction of cancellous bone to a nanocrystalline hydroxyapatite cement containing type I collagen (HA/Coll) and its modifications with sodium citrate (CI), calcium carbonate (CA), phosphoserine (P) and phosphoserine plus RGD-peptide (RGD). Cylindrical implants of HA/Coll and it...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2006.11.019

    authors: Schneiders W,Reinstorf A,Pompe W,Grass R,Biewener A,Holch M,Zwipp H,Rammelt S

    更新日期:2007-04-01 00:00:00

  • Changes in chemical composition of cortical bone associated with bone fragility in rat model with chronic kidney disease.

    abstract::Bone fragility is a complication of chronic kidney disease (CKD). Patients on dialysis have higher risk of fracture than the general population, but the reason remains obscure. Bone strength is determined by bone mass and bone quality. Although factors affecting bone quality include microarchitecture, remodeling activ...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2011.03.672

    authors: Iwasaki Y,Kazama JJ,Yamato H,Fukagawa M

    更新日期:2011-06-01 00:00:00

  • Does estrogen stimulate osteoblast function in postmenopausal women?

    abstract::How estrogen therapy influences bone metabolism in postmenopausal women has previously been studied using several approaches, including bone densitometry, measurement of biochemical markers of bone turnover, and histomorphometry. Taken together, these investigations suggest that conventional doses of estrogen protect ...

    journal_title:Bone

    pub_type: 杂志文章,评审

    doi:10.1016/s8756-3282(98)00156-2

    authors: Tobias JH,Compston JE

    更新日期:1999-02-01 00:00:00

  • Calcitonin-gene-related peptide stimulates stromal cell osteogenic differentiation and inhibits RANKL induced NF-kappaB activation, osteoclastogenesis and bone resorption.

    abstract::Previously we observed that capsaicin treatment in rats inhibited sensory neuropeptide signaling, with a concurrent reduction in trabecular bone formation and bone volume, and an increase in osteoclast numbers and bone resorption. Calcitonin-gene-related peptide (CGRP) is a neuropeptide richly distributed in sensory n...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2009.11.029

    authors: Wang L,Shi X,Zhao R,Halloran BP,Clark DJ,Jacobs CR,Kingery WS

    更新日期:2010-05-01 00:00:00

  • Disruption of the aldehyde dehydrogenase 2 gene increases the bone anabolic response to intermittent PTH treatment in an ovariectomized mouse model.

    abstract::Aldehyde dehydrogenase 2 (ALDH2) is the enzyme that oxidizes the acetaldehyde produced by alcohol metabolism. This variant not only affects the response to alcohol but is also associated with several diseases, such as esophageal cancer, myocardial infarction, and particularly osteoporosis. In our previous study, we re...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2020.115370

    authors: Kosugi K,Tajima T,Menuki K,Okuma KF,Tokuda K,Fukuda H,Okada Y,Tsukamoto M,Yamanaka Y,Zenke Y,Sakai A

    更新日期:2020-07-01 00:00:00

  • Vitamin D sterols increase FGF23 expression by stimulating osteoblast and osteocyte maturation in CKD bone.

    abstract::Impaired osteoblast and osteocyte maturation contribute to mineralization defects and excess FGF23 expression in CKD bone. Vitamin D sterols decrease osteoid accumulation and increase FGF23 expression; these agents also increase osteoblast maturation in vitro but a link between changes in bone cell maturation, bone mi...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2019.07.026

    authors: Pereira RC,Salusky IB,Bowen RE,Freymiller EG,Wesseling-Perry K

    更新日期:2019-10-01 00:00:00

  • Effect of whole-body vibration on bone properties in aging mice.

    abstract::Recent studies suggest that whole-body vibration (WBV) can improve measures of bone health for certain clinical conditions and ages. In the elderly, there also is particular interest in assessing the ability of physical interventions such as WBV to improve coordination, strength, and movement speed, which help prevent...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2010.07.014

    authors: Wenger KH,Freeman JD,Fulzele S,Immel DM,Powell BD,Molitor P,Chao YJ,Gao HS,Elsalanty M,Hamrick MW,Isales CM,Yu JC

    更新日期:2010-10-01 00:00:00

  • A novel homozygous mutation in the parathyroid hormone gene (PTH) in a girl with isolated hypoparathyroidism.

    abstract:CASE REPORT:A female patient with consanguineous parents presented with severe symptomatic hypocalcemia (1.62mmol/l) at the age of 4 months. Treatment with oral 1,25-(OH)2-vitamin D and calcium carbonate was started and serum calcium concentrations were stabilized at the lower end of the normal range. Subsequently she ...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2012.06.009

    authors: Ertl DA,Stary S,Streubel B,Raimann A,Haeusler G

    更新日期:2012-09-01 00:00:00

  • Lifelong risk factors for osteoporosis and fractures in elderly women with low body mass index--a population-based study.

    abstract::Low body weight is associated with an increased risk for osteoporosis and fractures, but the contribution of other lifestyle related factors have not been previously studied within lean elderly women. The present study evaluated the association between lifelong lifestyle factors and bone density, falls and postmenopau...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2006.01.143

    authors: Korpelainen R,Korpelainen J,Heikkinen J,Väänänen K,Keinänen-Kiukaanniemi S

    更新日期:2006-08-01 00:00:00

  • International variation in the management of mineral bone disorder in patients with chronic kidney disease: Results from CKDopps.

    abstract:BACKGROUND AND OBJECTIVES:Chronic kidney disease (CKD) is commonly associated with mineral and bone metabolism disorders, but these are less frequently studied in non-dialysis CKD patients than in dialysis patients. We examined and described international variation in mineral and bone disease (MBD) markers and their tr...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2019.115058

    authors: Liabeuf S,McCullough K,Young EW,Pisoni R,Zee J,Reichel H,Pecoits-Filho R,Port FK,Stengel B,Csomor PA,Metzger M,Robinson B,Massy ZA

    更新日期:2019-12-01 00:00:00

  • Systemic versus local application of gentamicin in prophylaxis of implant-related osteomyelitis in a rat model.

    abstract::Administration of perioperative antibiotic prophylaxis is a routine procedure in orthopedic surgery. Besides systemic prophylaxis, only few techniques are established for local application of antibiotics to reduce infection related to orthopedic implants. The aim of this study was to evaluate the efficacy of locally v...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2005.01.008

    authors: Lucke M,Wildemann B,Sadoni S,Surke C,Schiller R,Stemberger A,Raschke M,Haas NP,Schmidmaier G

    更新日期:2005-05-01 00:00:00

  • Whole-exome sequencing reveals a heterozygous LRP5 mutation in a 6-year-old boy with vertebral compression fractures and low trabecular bone density.

    abstract::Juvenile osteoporosis (JO) is characterized by bone fragility during development, low bone mass and absence of extraskeletal features. Heterozygous loss-of-function mutations in LRP5 have been found in a few patients, but bone tissue and bone material abnormalities associated with such mutations have not been determin...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2013.07.020

    authors: Fahiminiya S,Majewski J,Roughley P,Roschger P,Klaushofer K,Rauch F

    更新日期:2013-11-01 00:00:00

  • Osteocyte apoptosis regulates osteoclast precursor adhesion via osteocytic IL-6 secretion and endothelial ICAM-1 expression.

    abstract::Osteocyte apoptosis precedes osteoclast resorption, and may act as a critical signal to trigger bone remodeling. While osteoclast precursors are known to travel via the circulation, the specific mechanisms by which they accumulate at remodeling sites are unclear. We hypothesized that osteocyte apoptosis mediates osteo...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2011.09.052

    authors: Cheung WY,Simmons CA,You L

    更新日期:2012-01-01 00:00:00

  • Denosumab in postmenopausal women with osteoporosis and diabetes: Subgroup analysis of FREEDOM and FREEDOM extension.

    abstract:PURPOSE:Diabetes and osteoporosis occur frequently in older adults and are both associated with increased fracture risk. Denosumab treatment reduced new vertebral, nonvertebral, and hip fractures over 3 years, with continued low fracture incidence for up to 10 years in postmenopausal women with osteoporosis. However, i...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2020.115268

    authors: Ferrari S,Eastell R,Napoli N,Schwartz A,Hofbauer LC,Chines A,Wang A,Pannacciulli N,Cummings SR

    更新日期:2020-05-01 00:00:00

  • Effects of two oral doses of alendronate in the treatment of Paget's disease of bone.

    abstract::Twenty patients with mild Paget's disease of bone were given either 20 (10 patients) or 40 mg alendronate daily for 6 months. The 20-mg dose was well tolerated, but in 3 patients on 40 mg/d alendronate, the treatment was withdrawn after 3-5 months because of gastric and oesophageal disturbances. Urinary hydroxyproline...

    journal_title:Bone

    pub_type: 临床试验,杂志文章

    doi:10.1016/8756-3282(94)90818-4

    authors: Adami S,Mian M,Gatti P,Rossini M,Zamberlan N,Bertoldo F,Lo Cascio V

    更新日期:1994-07-01 00:00:00

  • Binding and antiresorptive properties of heterocycle-containing bisphosphonate analogs: structure-activity relationships.

    abstract::To define structure-activity relationships for bisphosphonate activity, we examined the bone binding and antiresorptive properties of heterocycle-containing analogs of risedronate, a pyridylbisphosphonate, in cultures of mouse fetal bone explants. Our studies indicated that hydroxybisphosphonates with the nitrogen mol...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/s8756-3282(98)00120-3

    authors: van Beek ER,Löwik CW,Ebetino FH,Papapoulos SE

    更新日期:1998-11-01 00:00:00

  • A comparative analysis of articular bone in large cohort of patients with chronic inflammatory diseases of the joints, the gut and the skin.

    abstract::Chronic inflammatory diseases are associated with bone loss. While the occurrence of systemic bone loss is well described in chronic inflammatory diseases, the impact of these conditions on articular bone has not been systematically investigated. Recent refinements in high-resolution CT assessment of the joints now al...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2018.07.017

    authors: Simon D,Kleyer A,Englbrecht M,Stemmler F,Simon C,Berlin A,Kocijan R,Haschka J,Hirschmann S,Atreya R,Neurath MF,Sticherling M,Rech J,Hueber AJ,Engelke K,Schett G

    更新日期:2018-11-01 00:00:00